Wednesday, January 18, 2012 5:45:48 PM
However, the best defenses against short-selling are strong fundamentals, which Healthnostics' unfolding business plan continues to support. This will be validated when the Initial Information and Disclosure Document for filing on the OTC Market reporting system is filed later this quarter.
... which went poof like magic - never happened.
The SEC has a million other things to do than investigate the supposed manipulation of a diluting, no information pink sheet company. If they are being looked at by SEC, it's not because of this. And if they are being investigated by the SEC, HNSS will be listed on the grays soon. IMO
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM